MYCN and neoplasm: To uncover how far collateral vulnerabilities can be directly induced by coamplified passenger genes, we performed a proof-of-principle analysis in models with MYCN amplifications, which are frequent in many tumor entities and are often associated with high-risk disease and poor therapeutic outcome (14).